How did you hear about us?


Attorneys for Justice, The Abelson Law Firm & Levin, Fishbein, Sedran and Berman, have a proud tradition of helping those who have been injured as a result of the negligence of others. We are pursuing individual litigation NATIONWIDE and currently accepting new Digitek recall and Digitlis toxicity cases in all 50 states. For over thirty years we have handled a variety of personal injury claims. Our mission is to seek justice and fair compensation for victims of dangerous medications. Digitek (also known as “digitalis” and “digoxin”) was recently recalled by its manufacturer Actavis because of a potentially fatal manufacturing defect.

A law firm with a national reputation that provides personalized attention to its clients, Levin, Fishbein, Sedran & Berman provides specialized representation to plaintiffs in complex personal injury and class action cases, involving practice areas that include anti-trust, consumer, pharmaceutical and products liability issues, medical malpractice, and other major personal injury cases.

Levin, Fishbein, Sedran & Berman have successfully prosecuted cases involving drug and pharmaceutical recall claims, defective products liability cases, mass tort and environmental liability exposure claims, and antitrust cases for the plaintiffs it has represented. Many of the cases have been litigated through the specialized Multidistrict Litigation process established by Congress for the consolidation and coordination of cases having common issues.

Recently, countless people were put in danger by a defective drug known as Digitek (digoxin). Manufactured by Actavis, Digitek is used to treat heart conditions such as congestive heart failure and abnormal heart rhythms. In April 2008, healthcare professionals were notified of a Class I nationwide recall of Digitek due to the possibility that tablets were released with double the appropriate thickness.

These overly potent tablets could contain twice the approved level of digitalis, the active ingredient in Digitek. The existence of double-strength pills poses a risk of digitalis toxicity, a serious condition which can result in heart attack, stroke, kidney failure, nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia (slow heart rate), and even death. Elderly patients and patients with renal failure are particularly at risk of developing digitalis toxicity.

The recall is restricted to Digitek tablets made by Actavis at their New Jersey facility because this facility apparently had been improperly manufacturing the pills for an unknown period of time. In early 2007, the Food and Drug Administration sent Actavis a revised warning letter after an agency inspection revealed that drug products manufactured in the facility were “adulterated.” The facility's quality control unit was criticized for failing to “reliably establish the identity, strength, quality, and purity of drug products manufactured and released onto the market.” The inspection also noted a lack of sufficient documentation of test results.

The Attorneys for Justice are now accepting cases nationwide involving pharmaceutical litigation such as the recall of defective Digitek tablets. We accept cases on a contingency fee basis (no attorneys fee if money is not recovered for the client). If you or a loved one has suffered a personal injury as a result of the Digitek medication error, please contact us online or toll free 1-888-797-4242 for a free consultation.